4th Quarter - Report
KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS for AGILE THERAPEUTICS
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Client
Income
$45,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 18, 2025 | $45,000 | Replaced |
| 4th Quarter - Termination | Apr 9, 2025 | $45,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to coverage of pharmaceutical products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANA SINGISER | Special Assistant to the President, The White House; Staff Director, Senate Democratic Steering and Outreach Committee |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.